Business
Result of AGM
Result of AGM.
About this update from Allergy Therapeutics Plc
[{"type":"text","content":"\n\n \n\n \nAllergy Therapeutics plc\n(\"Allergy Therapeutics\" or the \"Group\")\n \nResult of Annual General Meeting\n \n \n8 March 2024 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces that all resolutions proposed at the 2023 Annual General Meeting (\"AGM\") held today were duly passed by shareholders by way of poll vote.\n \nResolutions 1 to 11 (inclusive) were proposed as ordinary resolutions and resolutions 12 to 14 (inclusive) were proposed as special resolutions. The results of the proxy votes received ahead of the meeting are outlined in the table below.\n \n\n\n\n\nResolution\n\n\nFor:\n\n\n%age\n\n\nAgainst:\n\n\n%age\n\n\nTotal Votes Cast\n\n\nWithheld\n\n\n\n\n1. Approval of 2023 Accounts\n\n\n4,454,427,655\n\n\n100.00%\n\n\n100,000\n\n\n0.00%\n\n\n4,454,529,660\n\n\n2,005\n\n\n\n\n2. Approval of Directors'\nRemuneration Report\n\n\n4,440,353,568\n\n\n99.68%\n\n\n14,174,087\n\n\n0.32%\n\n\n4,454,529,660\n\n\n2,005\n\n\n\n\n3. To re-elect Mary Tavener as a Director\n\n\n4,454,239,121\n\n\n99.99%\n\n\n278,279\n\n\n0.01%\n\n\n4,454,529,660\n\n\n12,260\n\n\n\n\n4. To re-elect Tunde Otulana as a Director\n\n\n4,454,384,117\n\n\n100.00%\n\n\n133,283\n\n\n0.00%\n\n\n4,454,529,660\n\n\n12,260\n\n\n\n\n5. To re-elect Manuel Llobet as a Director\n\n\n4,454,284,117\n\n\n99.99%\n\n\n233,283\n\n\n0.01%\n\n\n4,454,529,660\n\n\n12,260\n\n\n\n\n6. To re-elect Cheryl MacDiarmid as a Director\n\n\n4,454,384,117\n\n\n100.00%\n\n\n133,283\n\n\n0.00%\n\n\n4,454,529,660\n\n\n12,260\n\n\n\n\n7. To re-elect Peter Jensen O.B.E. as a Director\n\n\n4,440,494,882\n\n\n99.69%\n\n\n14,015,154\n\n\n0.31%\n\n\n4,454,529,660\n\n\n19,624\n\n\n\n\n8. To re-appoint BDO LLP as auditors of the Company \n\n\n4,454,306,655\n\n\n100.00%\n\n\n221,000\n\n\n0.00%\n\n\n4,454,529,660\n\n\n2,005\n\n\n\n\n9. To authorise the Directors to agree the Auditors remuneration\n\n\n4,454,415,654\n\n\n100.00%\n\n\n108,001\n\n\n0.00%\n\n\n4,454,529,660\n\n\n6,005\n\n\n\n\n10. To authorise the Directors to allot the unissued share capital up to a specific amount (s.551)\n\n\n4,454,236,175\n\n\n99.99%\n\n\n291,480\n\n\n0.01%\n\n\n4,454,529,660\n\n\n2,005\n\n\n\n\n11. Authority to issue warrants\n\n\n4,440,359,504\n\n\n99.68%\n\n\n14,168,151\n\n\n0.32%\n...